Hepatitis B virus covalently closed circular DNA formation in immortalized mouse hepatocytes associated with nucleocapsid destabilization

Journal of Virology

Volumn 89, Issue 17, 2015, Pages 9021-9028

  Cui, Xiuji ^a   Guo, Ju Tao ^b   Hu, Jianming ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b BARUCH S BLUMBERG INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIRCULAR DNA; COVALENTLY CLOSED CIRCULAR DNA; UNCLASSIFIED DRUG; VIRUS DNA;

ANIMAL CELL; ARTICLE; CELL LINE; CONTROLLED STUDY; HEPATITIS B VIRUS; HOST RANGE; HUMAN; HUMAN CELL; LIVER CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; VIRAL TROPISM; VIRUS GENOME; VIRUS NUCLEOCAPSID; VIRUS REPLICATION; VIRUS UNCOATING; ANIMAL; BIOSYNTHESIS; CYTOLOGY; DNA REPLICATION; GENETICS; HEPATITIS B; VIROLOGY;

HEPATITIS B VIRUS;

ANIMALS; CELL LINE; DNA REPLICATION; DNA, CIRCULAR; DNA, VIRAL; HEPATITIS B; HEPATITIS B VIRUS; HEPATOCYTES; HUMANS; MICE; NUCLEOCAPSID; VIRUS REPLICATION;

EID: 84938916095     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01261-15     Document Type: Article

References (38)

1. Trepo C, Chan HL, Lok A. 2014. Hepatitis B virus infection. Lancet 384:2053-2063. http://dx.doi.org/10.1016/S0140-6736(14)60220-8.
2. Summers J, Mason WS. 1982. Replication of the genome of a hepatitis B-like virus by reverse transcription of an RNA intermediate. Cell 29:403-415. http://dx.doi.org/10.1016/0092-8674(82)90157-X.
3. Seeger C, Zoulim F, Mason WS. 2013. Hepadnaviruses, p 2185-2221. In Knipe DM, Howley PM, Cohen JI, Griffin DE, Lamb RA, Martin MA, Racaniello VR, Roizman B (ed), Fields virology, 6th ed. Lippincott Williams & Wilkins, Philadelphia, PA.
4. Wang GH, Seeger C. 1992. The reverse transcriptase of hepatitis B virus acts as a protein primer for viral DNA synthesis. Cell 71:663-670. http://dx.doi.org/10.1016/0092-8674(92)90599-8.
5. Hu J, Seeger C. 2015. Hepadnavirus genome replication and persistence. Cold Spring Harb Perspect Med http://dx.doi.org/10.1101/cshperspect.a021386.
6. Mason WS, Halpern MS, England JM, Seal G, Egan J, Coates L, Aldrich C, Summers J. 1983. Experimental transmission of duck hepatitis B virus. Virology 131:375-384. http://dx.doi.org/10.1016/0042-6822(83)90505-6.
7. Miller RH, Robinson WS. 1984. Hepatitis B virus DNA forms in nuclear and cytoplasmic fractions of infected human liver. Virology 137:390-399. http://dx.doi.org/10.1016/0042-6822(84)90231-9.
8. Tuttleman JS, Pourcel C, Summers J. 1986. Formation of the pool of covalently closed circular viral DNA in hepadnavirus-infected cells. Cell 47:451-460. http://dx.doi.org/10.1016/0092-8674(86)90602-1.
9. Wu TT, Coates L, Aldrich CE, Summers J, Mason WS. 1990. In hepatocytes infected with duck hepatitis B virus, the template for viral RNA synthesis is amplified by an intracellular pathway. Virology 175:255-261. http://dx.doi.org/10.1016/0042-6822(90)90206-7.
10. Gao W, Hu J. 2007. Formation of hepatitis B virus covalently closed circular DNA: removal of genome-linked protein. J Virol 81:6164-6174. http://dx.doi.org/10.1128/JVI.02721-06.
11. Guidotti LG, Matzke B, Schaller H, Chisari FV. 1995. High-level hepatitis B virus replication in transgenic mice. J Virol 69:6158-6169.
12. Guo H, Jiang D, Zhou T, Cuconati A, Block TM, Guo JT. 2007. Characterization of the intracellular deproteinized relaxed circular DNA of hepatitis B virus: an intermediate of covalently closed circular DNA formation. J Virol 81:12472-12484. http://dx.doi.org/10.1128/JVI.01123-07.
13. Lentz TB, Loeb DD. 2011. Roles of the envelope proteins in the amplification of covalently closed circular DNA and completion of synthesis of the plus-strand DNA in hepatitis B virus. J Virol 85:11916-11927. http://dx.doi.org/10.1128/JVI.05373-11.
14. Summers J, Smith PM, Horwich AL. 1990. Hepadnavirus envelope proteins regulate covalently closed circular DNA amplification. J Virol 64:2819-2824.
15. Summers J, Smith PM, Huang MJ, Yu MS. 1991. Morphogenetic and regulatory effects of mutations in the envelope proteins of an avian hepadnavirus. J Virol 65:1310-1317.
16. Cui X, Ludgate L, Ning X, Hu J. 2013. Maturation-associated destabilization of hepatitis B virus nucleocapsid. J Virol 87:11494-11503. http://dx.doi.org/10.1128/JVI.01912-13.
17. Liu K, Ludgate L, Yuan Z, Hu J. 2015. Regulation of multiple stages of hepadnavirus replication by the carboxyl-terminal domain of viral core protein in trans. J Virol 89:2918-2930. http://dx.doi.org/10.1128/JVI.03116-14.
18. Basagoudanavar SH, Perlman DH, Hu J. 2007. Regulation of hepadnavirus reverse transcription by dynamic nucleocapsid phosphorylation. J Virol 81:1641-1649. http://dx.doi.org/10.1128/JVI.01671-06.
19. Rabe B, Vlachou A, Pante N, Helenius A, Kann M. 2003. Nuclear import of hepatitis B virus capsids and release of the viral genome. Proc Natl Acad Sci U S A 100:9849-9854. http://dx.doi.org/10.1073/pnas.1730940100.
20. Xu C, Guo H, Pan XB, Mao R, Yu W, Xu X, Wei L, Chang J, Block TM, Guo JT. 2010. Interferons accelerate decay of replication-competent nucleocapsids of hepatitis B virus. J Virol 84:9332-9340. http://dx.doi.org/10.1128/JVI.00918-10.
21. Wu JC, Merlino G, Fausto N. 1994. Establishment and characterization of differentiated, nontransformed hepatocyte cell lines derived from mice transgenic for transforming growth factor alpha. Proc Natl Acad Sci U S A 91:674-678. http://dx.doi.org/10.1073/pnas.91.2.674.
22. Ladner SK, Otto MJ, Barker CS, Zaifert K, Wang GH, Guo JT, Seeger C, King RW. 1997. Inducible expression of human hepatitis B virus (HBV) in stably transfected hepatoblastoma cells: a novel system for screening potential inhibitors of HBV replication. Antimicrob Agents Chemother 41:1715-1720.
23. Pasquetto V, Wieland SF, Uprichard SL, Tripodi M, Chisari FV. 2002. Cytokine-sensitive replication of hepatitis B virus in immortalized mouse hepatocyte cultures. J Virol 76:5646-5653. http://dx.doi.org/10.1128/JVI.76.11.5646-5653.2002.
24. Hu J, Flores D, Toft D, Wang X, Nguyen D. 2004. Requirement of heat shock protein 90 for human hepatitis B virus reverse transcriptase function. J Virol 78:13122-13131. http://dx.doi.org/10.1128/JVI.78.23.13122-13131.2004.
25. Perlman DH, Berg EA, O'Connor PB, Costello CE, Hu J. 2005. Reverse transcription-associated dephosphorylation of hepadnavirus nucleocapsids. Proc Natl Acad Sci U S A 102:9020-9025. http://dx.doi.org/10.1073/pnas.0502138102.
26. Nguyen DH, Gummuluru S, Hu J. 2007. Deamination-independent inhibition of hepatitis B virus reverse transcription by APOBEC3G. J Virol 81:4465-4472. http://dx.doi.org/10.1128/JVI.02510-06.
27. Garcia ML, Byfield R, Robek MD. 2009. Hepatitis B virus replication and release are independent of core lysine ubiquitination. J Virol 83:4923-4933. http://dx.doi.org/10.1128/JVI.02644-08.
28. Pagliaccetti NE, Chu EN, Bolen CR, Kleinstein SH, Robek MD. 2010. Lambda and alpha interferons inhibit hepatitis B virus replication through a common molecular mechanism but with different in vivo activities. Virology 401:197-206. http://dx.doi.org/10.1016/j.virol.2010.02.022.
29. Robek MD, Boyd BS, Chisari FV. 2005. Lambda interferon inhibits hepatitis B andCvirus replication. J Virol 79:3851-3854. http://dx.doi.org/10.1128/JVI.79.6.3851-3854.2005.
30. Guo H, Mao R, Block TM, Guo JT. 2010. Production and function of the cytoplasmic deproteinized relaxed circular DNA of hepadnaviruses. J Virol 84:387-396. http://dx.doi.org/10.1128/JVI.01921-09.
31. Ning X, Nguyen D, Mentzer L, Adams C, Lee H, Ashley R, Hafenstein S, Hu J. 2011. Secretion of genome-free hepatitis B virus-single strand blocking model for virion morphogenesis of para-retrovirus. PLoS Pathog 7:e1002255. http://dx.doi.org/10.1371/journal.ppat.1002255.
32. Luckenbaugh L, Kitrinos KM, Delaney WE, Hu J. 2015. Genome-free hepatitis B virion levels in patient sera as a potential marker to monitor response to antiviral therapy. J Viral Hepat 22:561-570. http://dx.doi.org/10.1111/jvh.12361.
33. Ludgate L, Adams C, Hu J. 2011. Phosphorylation state-dependent interactions of hepadnavirus core protein with host factors. PLoS One 6:e29566. http://dx.doi.org/10.1371/journal.pone.0029566.
34. Kann M, Gerlich WH. 1994. Effect of core protein phosphorylation by protein kinase C on encapsidation of RNA within core particles of hepatitis B virus. J Virol 68:7993-8000.
35. Raney AK, Eggers CM, Kline EF, Guidotti LG, Pontoglio M, Yaniv M, McLachlan A. 2001. Nuclear covalently closed circular viral genomic DNAin the liver of hepatocyte nuclear factor 1 alpha-null hepatitis B virus transgenic mice. J Virol 75:2900-2911. http://dx.doi.org/10.1128/JVI.75.6.2900-2911.2001.
36. Ni Y, Lempp FA, Mehrle S, Nkongolo S, Kaufman C, Falth M, Stindt J, Koniger C, Nassal M, Kubitz R, Sultmann H, Urban S. 2014. Hepatitis B and D viruses exploit sodium taurocholate co-transporting polypeptide for species-specific entry into hepatocytes. Gastroenterology 146:1070-1083. http://dx.doi.org/10.1053/j.gastro.2013.12.024.
37. Yan H, Zhong G, Xu G, He W, Jing Z, Gao Z, Huang Y, Qi Y, Peng B, Wang H, Fu L, Song M, Chen P, Gao W, Ren B, Sun Y, Cai T, Feng X, Sui J, Li W. 2012. Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus. eLife 1:e00049. http://dx.doi.org/10.7554/eLife.00049.
38. He W, Ren B, Mao F, Jing Z, Li Y, Liu Y, Peng B, Yan H, Qi Y, Sun Y, Guo JT, Sui J, Wang F, Li W. 2015. Hepatitis D virus infection of mice expressing human sodium taurocholate co-transporting polypeptide. PLoS Pathog 11:e1004840. http://dx.doi.org/10.1371/journal.ppat.1004840.